FANCA and Fanconi anemia: To this aim lymphoblastoid cell lines derived from Fanconi anemia (FA) patients which bear defects in the FANCA gene (LFA55−/− and LFA145−/−) and their normal counterpart, LFA 195++ cell line, derived from a healthy relative of one FA patient (LFA145−/−) were used (see M&M).